retatrutide cagrilintide Cagrilintide, Tirzepatide, and Peptides: Comparing Metabolic Mechanisms Cagrilintide vs Retatrutide Compared |

Moreover, a favorable impact of GLP-1RAs on cardiac remodeling can occur through activation of the eNOS/cyclic guanosine monophosphate (cGMP)/protein kinase G (PKG) nexus [72]

The bottom line is simple: retatrutide is not currently an FDA-approved prescription medicine

Gastrointestinal side effects, including nausea, vomiting, diarrhea, and constipation, are common with GLP-1 receptor agonists

Novo Nordisk A/S Novo Nordisk has a commanding presence in the T2D market, particularly with semaglutide-based therapies, which have become symbolic of the GLP-1 dominance era

Retatrutide Dosage Based on Clinical Studies: The Scientific Foundation Dosing guidelines for retatrutide are based on the Phase 2 data published by Jastreboff and colleagues in NEJM (2023) and, as of 2026, on the first Phase 3 data from TRIUMPH-4